CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals Inc. (AMEX: IDP), a biopharmaceutical company focused on developing therapeutics targeting Toll-like Receptors (TLR), today reported financial results for the quarter and year ended December 31, 2006.
